Company: Halodoc

Title: Co-Founder & Chief Business Officer


Residing Country: Indonesia

Industry: Digital Health

Joint Nominee: Jonathan Sudharta, Co-Founder & CEO



Doddy Lukito is the Chief Business Officer and Co-Founder of Halodoc. He is responsible for ensuring sustainable business models for Halodoc: from technological integration, initiative mapping, to identifying collaboration opportunities for both offline and online businesses. He has over 20 years of experience in the technology industry. 

Building Halodoc from the ground up, Doddy served in various key roles as the company grew, from Chief Technology Officer (CTO) to the Chief Operating Officer (COO), and now as Chief Business Officer (CBO). He also has experience in the investment sector during his time at InvestIdea, in which he served as General Partner. Prior to establishing Halodoc, he worked as a CTO for several local startups, namely EazyTravel, LinkDokter and Bistip.  


The disruptive innovation.

Doddy and Jonathan cofounded Halodoc in 2016 with the idea of simplifying healthcare access through technology. Initially launched with two key features: doctor consultation and pharmaceuticals delivery, Halodoc has expanded into multiple verticals to provide end-to-end solutions for the healthcare pains experienced by Indonesians. 

To provide access to safe and secure #COVID19 tests, Halodoc collaborated with clinics to set up drive thru facilities. Launched in April 2020, the service has expanded to locations across 5 major cities in Indonesia, namely Jakarta, Bandung, Semarang, Surabaya, and Bali. As of Dec 2020, the facilities have conducted more than 500,000 tests, which helped minimize pressure for local health facility to focus on severe cases.  

Halodoc’s monthly active users totalled around 7 million pre-pandemic to 22 million as of June 2020, marking a more than 700% revenue increase. Halodoc is also the first telemedicine that launched an online vet consultation service, allowing users to maintain their pet's health during the pandemic and enabling vets to still generate income.